Item 9 Labs Corp.
INLB
Revenue
5.02M
▼-640.63k▼-11.31%
3 Months ChangeAssets
112.02M
▼-2.11M▼-1.85%
3 Months ChangeLiabilities
59.37M
▲2.93M▲5.19%
3 Months ChangeFree Cash Flow
-1.34M
▲1.42M▲51.40%
6 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2023-08-21
Form 10-Q
ID: 0001554795-23-000272
2023-07-20
Form 8-K
ID: 0001554795-23-000219
2023-07-07
Form 8-K
ID: 0001554795-23-000204
2023-06-27
Form 8-K
ID: 0001554795-23-000190
2023-06-06
Form 8-K
ID: 0001554795-23-000188
2023-05-22
Form 10-Q
ID: 0001554795-23-000186
2023-05-22
Form 8-K
ID: 0001554795-23-000184
2023-05-12
Form 8-K
ID: 0001554795-23-000158
2023-05-05
Form 8-K
ID: 0001554795-23-000148
2023-04-05
Form 8-K
ID: 0001554795-23-000111